Nyxoah S.A. | Mid-cap | Healthcare
€4.26
-0.58%
| Nyxoah S.A Stock Comparison:
Nyxoah S.A vs Argenx SENyxoah S.A vs UCB S.ANyxoah S.A vs Fagron NVNyxoah S.A vs Ion BeamNyxoah S.A vs Onward Medical N.VNyxoah S.A vs BEL 20 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 1.3M
Gross Profit 850.0K 63.43%
Operating Income -19.8M -1,481.34%
Net Income -20.6M -1,537.84%
EPS (Diluted) €-0.55

Balance Sheet Metrics

Total Assets 116.5M
Total Liabilities 43.1M
Shareholders Equity 73.4M
Debt to Equity 0.59

Cash Flow Metrics

Operating Cash Flow -14.1M
Free Cash Flow -13.7M

Revenue & Profitability Trend

Nyxoah S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.5M4.3M3.1M852.0K69.0K
Cost of Goods Sold i1.6M1.7M1.2M303.0K30.0K
Gross Profit i3.0M2.7M1.9M549.0K39.0K
Gross Margin % i65.7%61.9%62.7%64.4%56.5%
Operating Expenses
Research & Development i34.4M27.7M16.0M13.0M2.3M
Selling, General & Administrative i27.2M20.6M17.9M14.0M8.8M
Other Operating Expenses i-1.1M-1.5M-406.0K-880.0K-459.0K
Total Operating Expenses i60.5M46.8M33.5M26.1M10.7M
Operating Income i-58.8M-45.1M-32.5M-26.2M-11.2M
Operating Margin % i-1,300.8%-1,037.3%-1,053.8%-3,080.0%-16,266.7%
Non-Operating Items
Interest Income i2.5M2.6M372.0K1.0K3.0K
Interest Expense i886.0K217.0K237.0K386.0K198.0K
Other Non-Operating Income1.8M-925.0K2.9M3.2M39.0K
Pre-tax Income i-56.4M-44.7M-30.1M-24.6M-12.2M
Income Tax i2.8M-1.4M1.2M3.0M93.0K
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-59.2M-43.2M-31.2M-27.6M-12.2M
Net Margin % i-1,310.2%-993.8%-1,012.5%-3,241.7%-17,746.4%
Key Metrics
EBITDA i-54.6M-41.2M-30.8M-25.8M-11.4M
EPS (Basic) i€-1.81€-1.55€-1.21€-1.16€-0.68
EPS (Diluted) i€-1.81€-1.55€-1.21€-1.16€-0.68
Basic Shares Outstanding i3274516327968142258271302380948318097988
Diluted Shares Outstanding i3274516327968142258271302380948318097988

Income Statement Trend

Nyxoah S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i34.2M21.6M17.9M135.5M92.3M
Short-term Investments i51.4M36.1M77.0M0-
Accounts Receivable i3.4M2.8M1.5M226.0K0
Inventory i4.7M3.3M882.0K346.0K55.0K
Other Current Assets1.7M1.3M1.3M1.7M109.0K
Total Current Assets i98.1M68.4M100.3M140.1M94.1M
Non-Current Assets
Property, Plant & Equipment i1.9M1.5M1.2M858.0K164.0K
Goodwill i50.4M46.6M40.0M25.3M15.9M
Intangible Assets i50.4M46.6M40.0M25.3M15.9M
Long-term Investments-----
Other Non-Current Assets1.7M1.2M220.0K210.0K122.0K
Total Non-Current Assets i60.3M55.8M45.8M30.8M20.0M
Total Assets i158.4M124.2M146.1M170.8M114.1M
Liabilities
Current Liabilities
Accounts Payable i3.7M4.1M1.9M2.4M815.0K
Short-term Debt i1.4M1.2M1.1M1.1M1.1M
Current Portion of Long-term Debt-----
Other Current Liabilities1.5M90.0K9.0K654.0K-
Total Current Liabilities i21.5M14.4M14.9M11.6M6.4M
Non-Current Liabilities
Long-term Debt i21.3M11.5M10.8M10.5M10.5M
Deferred Tax Liabilities i19.0K9.0K05.0K0
Other Non-Current Liabilities845.0K----
Total Non-Current Liabilities i23.6M11.7M10.8M10.6M10.5M
Total Liabilities i45.2M26.1M25.7M22.2M16.9M
Equity
Common Stock i6.4M4.9M4.4M4.4M3.8M
Retained Earnings i-217.7M-160.8M-118.2M-87.2M-60.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i113.3M98.0M120.3M148.6M97.2M
Key Metrics
Total Debt i22.7M12.7M11.9M11.7M11.5M
Working Capital i76.6M53.9M85.3M128.5M87.7M

Balance Sheet Composition

Nyxoah S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-56.4M-44.7M-30.1M-24.6M-12.2M
Depreciation & Amortization i2.7M2.4M1.9M1.7M620.0K
Stock-Based Compensation i4.0M2.6M2.7M1.3M2.5M
Working Capital Changes i-2.2M-4.0M-529.0K-2.8M310.0K
Operating Cash Flow i-52.8M-44.7M-29.0M-26.7M-7.9M
Investing Activities
Capital Expenditures i-1.2M-2.5M-886.0K-1.5M-562.0K
Acquisitions i-----
Investment Purchases i-97.8M-80.0M-102.6M0-13.0K
Investment Sales i85.3M120.7M28.9M00
Investing Cash Flow i-13.7M38.2M-74.6M-1.5M-575.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i00000
Debt Issuance i10.0M-001.2M
Debt Repayment i-1.5M-1.2M-1.1M-863.0K-597.0K
Financing Cash Flow i77.9M17.0M-853.0K76.9M104.2M
Free Cash Flow i-55.3M-55.7M-45.1M-37.2M-17.5M
Net Change in Cash i11.4M10.5M-104.4M48.7M95.7M

Cash Flow Trend

Nyxoah S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -2.36
Forward P/E -2.47
Price to Book 2.17
Price to Sales 32.46
PEG Ratio -0.08

Profitability Ratios

Profit Margin 65.67%
Operating Margin -1,481.34%
Return on Equity -79.77%
Return on Assets -34.84%

Financial Health

Current Ratio 2.63
Debt to Equity 30.52
Beta 0.60

Per Share Data

EPS (TTM) €-2.11
Book Value per Share €1.96
Revenue per Share €0.14

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
nyxh160.1M-2.362.17-79.77%65.67%30.52
Argenx SE 38.4B37.826.3324.72%41.03%0.71
UCB S.A 39.1B29.724.0014.30%19.45%29.72
Fagron NV 1.4B16.722.8517.53%9.33%80.02
Ion Beam 323.7M18.762.8816.20%2.89%56.98
Onward Medical N.V 238.0M-6.668.45-167.80%90.39%54.33

Financial data is updated regularly. All figures are in the company's reporting currency.